🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,911 results for “Pharma” Clear

  1. -, COLESTYRAMINE , AUBAGIO 14 mg film-coated tablets, -, Matched Placebo to Test, Tolebrutinib, Matched Placebo for Comparator Teriflunomide

    Sanofi Pharma Bristol-Myers Squibb

    Nervous system diseases

    phase 3 small molecule active

    1 trial

  2. -, PARACETAMOL , CILAZAPRIL , Dapirolizumab pegol, EPINEPHRINE , DIPHENHYDRAMINE , -, -, -, -, -, -, -

    Pharma Mar S.A.

    Systemic lupus erythematosus (SLE)

    phase 3 small molecule active

    1 trial

  3. -, Rozanolixizumab

    Pharma Mar S.A.

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  4. -, Rozanolixizumab

    Pharma Mar S.A.

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  5. -, Sodium butyrate 1,1 g/L sol prep

    ISTA Pharma Limited

    Hirschsprung's disease

    phase 3 small molecule active

    1 trial

  6. -, TACROLIMUS , Amlitelimab, PIMECROLIMUS , Placebo, Amlitelimab

    Sanofi Pharma Bristol-Myers Squibb

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  7. -, VALSARTAN AND SACUBITRIL , CARVEDILOL , DAPAGLIFLOZIN , -, RAMIPRIL , -, -, LOSARTAN

    Pari Pharma GmbH

    Heart failure

    phase 3 small molecule active

    1 trial

  8. 0.05% Voclosporin Ophthalmic Solution (VOS)

    Aurinia Pharmaceuticals

    Dry Eye Syndrome

    phase 3 small molecule completed

    1 trial

  9. 0.9% Sodium Chloride Solution, Glenzocimab

    Pari Pharma GmbH

    Acute ischemic stroke

    phase 3 small molecule active

    1 trial

  10. 0.9% Sodium Chloride, JNJ-78901563

    Janssen Pharmaceutica N.V.

    Invasive Extraintestinal Pathogenic Escherichia coli Disease

    phase 3 small molecule active

    1 trial

  11. 1% Clascoterone Cream

    Sunshine Biopharma

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  12. 131I-apamistamab

    Actinium Pharmaceuticals

    Acute Leukemia

    phase 3 small molecule active

    1 trial

  13. 18F-DPA-714

    Pari Pharma GmbH

    Multiple sclerosis

    phase 3 small molecule active

    1 trial

  14. 20 mg VEC-162

    Vanda Pharmaceuticals Netherlands B.V.

    Insomnia

    phase 3 small molecule completed

    1 trial

  15. 25 mg Ontamalimab

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  16. 2mg Baricitinib

    China SXT Pharmaceuticals

    Acute Ichemic Stroke

    phase 3 small molecule active

    1 trial

  17. 35 mg oral lyophilisate, 25 mg oral lyophilisate, 50 mg oral lyophilisate, VYDURA 75 mg oral lyophilisate

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Acute Migraine (with or without aura)

    phase 3 small molecule active

    1 trial

  18. 5% Lidocaine patch

    China SXT Pharmaceuticals

    Herpes Zoster Pain

    phase 3 small molecule completed

    1 trial

  19. 5% cysteamine cream

    China SXT Pharmaceuticals

    Melasma

    phase 3 other completed

    1 trial

  20. 5% minoxidil foam

    Sunshine Biopharma

    Androgenetic Alopecia

    phase 3 small molecule active

    1 trial

  21. 5-Fu/epirubicin/CTX following Docetaxel

    China SXT Pharmaceuticals

    Breast Cancer

    phase 3 small molecule active

    1 trial

  22. 601 1.25mg

    Sunshine Biopharma

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

  23. 608

    Sunshine Biopharma

    Axial Spondyloarthritis, Non-Radiographic

    phase 3 small molecule active

    1 trial

  24. 608 Q2W

    Sunshine Biopharma

    Plaque Psoriasis Patients

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources